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Abstract   
The uptake of nanomaterials (NMs) by cells is critical in determining their potential biological 
impact, whether beneficial or detrimental. Thus, investigation of NM internalisation by cells is a 
common consideration in hazard and efficacy studies. There are currently a number of 
approaches that are routinely used to investigate NM-cell interactions, each of which have their 
own advantages and limitations. Ideally, imaging modalities used to investigate NM uptake by 
cells should not require the NM to be labelled (e.g. with fluorophores) to facilitate its detection.	
We present a multimodal imaging approach employing a combination of label-free microscopies 
that can be used to investigate NM-cell interactions. Coherent anti-Stokes Raman scattering 
(CARS) microscopy was used in combination with either two-photon photoluminescence (TPPL) 
or four-wave mixing (FWM) to visualise the uptake of gold or titanium dioxide NMs respectively. 
Live and fixed cell imaging revealed that NMs were internalised by J774 macrophage and C3A 
hepatocyte cell lines (15-31µg/ml). Sprague Dawley rats were exposed to NMs (intratracheal 
instillation, 62µg) and NMs were detected in blood and lung leukocytes, lung and liver tissue, 
demonstrating that NMs could translocate from the exposure site. Obtained data illustrate that 
multimodal nonlinear optical microscopy may help overcome current challenges in the 
assessment of NM cellular uptake and biodistribution. It is therefore a powerful tool that can be 
used to investigate unlabelled NM cellular and tissue uptake in three dimensions, requires 
minimal sample preparation, and is applicable to live and fixed cells. 
 
Keywords: nanomaterial, uptake, microscopy, CARS, imaging, biodistribution  
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Introduction  
Investigating the uptake of diverse forms of nanomaterials (NMs) (e.g. metal oxides, metals, 
polymers, and carbon based structures) by cells and tissues is critical in determining their 
potential biological impact, whether beneficial or detrimental. The uptake of NMs by cells may 
be a requirement for their toxicity, and so visualising NM-cell interactions is often a key 
component of in hazard studies. Furthermore, an understanding of NM biodistribution in the 
body is essential to inform the design of hazard studies (e.g. to identify potential target sites of 
NM toxicity) and to evaluate the longevity of NMs in the body following exposure. The increased 
development of nanomedicines and nano-scale medical devices also requires that a better 
understanding of their cellular uptake and biodistribution is obtained prior to their widespread 
use in order to ensure they are targeted to the required site in the body, interact with specific 
target cells, and that they do not stimulate adverse health effects. Imaging the uptake of NMs by 
cells and tissues is therefore now a routine consideration in hazard and efficacy investigations 
for NMs.  Ideally, imaging modalities used to examine NM-cell interactions should not require 
the NM to be modified (e.g. with fluorophores) to facilitate NM detection, should involve minimal 
sample processing, be applicable to fixed or live cells, be able to confirm that NMs are 
internalised into the cell interior, and should be able to quantify NM uptake. 
 
Probing interactions between NMs and cells has routinely been investigated using fluorescent 
NMs. The uptake of NMs such as fluorescent polystyrene beads and quantum dots by a variety 
of cell and tissue types including; macrophages [1,2], hepatocytes [3], red blood cells [4], 
fibroblasts [5], keratinocytes [6], lung tissue [2] and skin tissue [7] has been investigated 
previously. Confocal microscopy has been frequently used as it is applicable to fixed and live 
cells, and allows images to be taken in different focal planes to confirm NM internalisation into 
the cell interior. However, few forms of intrinsically fluorescent NMs exist, and thus NMs have 
been labelled with fluorescent tags in order to enable their visualisation (e.g. [8]). The addition of 
fluorescent labels may alter NM physico-chemical characteristics and thus behaviour, many 
fluorescent tags are not stable, they may be chemically or photo-bleached, and become 
detached (e.g. 9-11). Accordingly, it is desirable to use imaging modalities that do not require 
NM modification to enable their detection.  
For non-fluorescent NMs there are a number of approaches which have been used to detect 
NM-cell interactions, each of which have their own advantages and limitations. The unique 
optical properties exhibited by NMs can be exploited when imaging their uptake by cells. For 
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example, ultrafine carbon black and carbon nanotubes can be visualised due to their black 
colour using bright-field light microscopy (e.g. [12-14]). However, the resolution of light 
microscopy is not sufficient to identify single NMs, it is difficult to distinguish between NMs that 
are internalised by cells and those that are attached to the cell surface and does not permit the 
assessment of NM sub-cellular location.  
As some NMs can scatter light, dark-field microscopy can be used to image their internalisation 
by cells. This technique has been used to visualise a variety of NM types including gold [15, 16], 
and TiO2 [17]. This technique has the advantage that the NMs do not need to be modified to 
enable their detection, however, the usefulness of dark field microscopy relies on the inherent 
light scattering properties of NMs [17], and so is not applicable to all NMs, and may vary with 
the physico-chemical form of the NM [18]. A combination of dark field microscopy and confocal 
microscopy can enable the internalisation of NMs by cells to be confirmed as confocal 
microscopy can image in 3 dimensions [17]. Alternatively, images taken at different focal planes 
of a cell have been used to establish whether NMs are taken into the cell interior or remain at 
the cell surface [15]. 
Transmission electron microscopy (TEM) has sufficient resolution to image individual NMs, and 
has been used to successfully image the uptake and sub-cellular localisation of NMs, and 
evaluate the mechanism of NM uptake in a variety of cell types and tissues including; 
macrophages [4], hepatocytes [19], fibroblasts [20], skin [21], and intestine [22]. However, there 
are often difficulties in discriminating NMs from cellular structures. This has been overcome 
through the use of TEM with other imaging modalities (e.g. dark field microscopy) to enhance 
contrast and therefore aid the visualisation of NMs [23]. In addition, TEM can be coupled to 
other techniques to confirm NM uptake by performing an elemental analysis to produce a more 
informative image [24-30]. Yet of general concern is that TEM sample preparation may 
introduce artefacts, is very time intensive, costly, and cannot be used to perform imaging 
studies with live cells [17].  
CARS microscopy is a multi-photon imaging technique which allows cells to be imaged without 
requiring the use of extrinsic labels such as fluorophores [31]. CARS microscopy is suitable for 
imaging unstained biological samples in real time with high three-dimensional (3D) spatial 
resolution and requires minimal sample processing. CARS microscopy utilises a resonant form 
of Raman scattering, where chemical bonds in molecules are stimulated into a vibrational state 
characteristic of their chemical structure. It is a third order nonlinear optical process in which 
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molecular vibrations are driven coherently through stimulated excitation by pulsed lasers. Due to 
the nonlinear nature of the process the signal is greatly amplified over traditional Raman 
spectroscopy, thus allowing imaging at high speed and high sensitivity. In the CARS process 
two laser pulses are required; a pump beam at frequency ωp and a Stokes beam at frequency 
ωs which interact with the sample in a four-wave mixing (FWM) process. When the frequency 
ωp−ωs matches that of a Raman active molecular vibration, the chemical bonds are excited 
resonantly generating a strong anti-Stokes signal at ωas=2ωp−ωs. This enables contrast to be 
derived from intrinsic sample properties (e.g. a stretching vibration in methyl moieties is highly 
characteristic of lipids), removing the need to label the sample to visualise the cell structure. 
CARS microscopy is not, however, background-free; the non-resonant background, an inherent 
electronic contribution to the CARS signal that is independent of the Raman shift, can 
overwhelm the vibrational contrast. For most applications in CARS microscopy investigators 
strive to minimise the non-resonant contributions and hence optimise image contrast.  In this 
study, we will exploit this non-resonant signal to generate contrast from metal and metal oxide 
NMs.  Metallic NMs are known to have large non-linear susceptibilities that are enhanced by 
two-photon electronic resonance, making them efficient candidates for four-wave mixing 
process, like CARS microscopy. TiO2 NMs show a large FWM signal, whilst Au NMs exhibit two-
photon photoluminescence (TPPL) which is enhanced by surface plasmons. These two 
nonlinear optical phenomena were exploited to localise different types of NMs within biological 
samples at the cellular level. 
Despite its ability to image a diverse array of unmodified NMs, CARS microscopy has only been 
used to a very limited extent to image NM interaction with cells. However, existing studies have 
demonstrated the usefulness of CARS microscopy in imaging; the uptake of metal oxide NMs 
(e.g. TiO2, ZnO, and CeO2) by fish (gills) [32, 33], the uptake of SWCNTs by the sediment 
dwelling organism Arenicola marina (lugworm) [34], and the internalisation of gold NMs by 
macrophages [35] and epidermal keratinocytes and squamous carcinoma cells [36]. The 
majority of published studies which have investigated NM-cell/tissue interactions using CARS 
microscopy have focused on environmental organisms. The usefulness of this imaging modality 
to investigate NM uptake by more diverse (mammalian) cells and tissues for the hazard and 
efficacy assessment of NMs has not been rigorously assessed.  
This study assessed the suitability of using CARS microscopy, in combination with other 
imaging modalities (termed NLO microscopy), to investigate NM-cell interactions.. Importantly, 
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NMs were not modified to enable their detection, and samples (cells and tissues) investigated 
were not stained to visualise cell or tissue structure (i.e. imaging is label free). The study aimed 
to assess whether NLO microscopy could be used to i) investigate the uptake of unlabelled 
NMs, of varied physico-chemical properties, by cells in 3 dimensions (i.e. in order to confirm NM 
uptake into the cell interior), and ii) assess the uptake of unlabelled NMs by live and fixed cells, 
and fixed tissues in order to demonstrate that NLO microscopy is a useful tool that can be 
applied to a range of biological samples obtained from in vitro and in vivo studies. The 
mechanism of NM uptake and their intracellular fate was not investigated, and NM cellular 
uptake was not quantified. In the first instance the uptake of NMs (TiO2 and gold (Au)) by 
macrophage and hepatocyte cell lines was evaluated in fixed and live cells. NM uptake by 
tissues (lung and liver) and leukocytes (obtained from lung or blood) was then investigated 
following the exposure of rats to NMs via intratracheal instillation. The study focused on cell 
types that are known to be capable of internalising NMs, and organs known to accumulate NMs. 
More specifically, there is a wealth of evidence available which illustrates that macrophages 
located in different tissues (e.g. lung, liver) accumulate NMs following the exposure of rodents 
(e.g. [4, 37-40]) and that macrophage cell lines and primary cells are capable of internalising 
NMs in vitro (e.g. [1]). The liver is a recognised site of NM accumulation in vivo (e.g. [41]), and 
there is evidence that hepatocytes are able to internalise NMs in vitro [3, 19, 42]. NM 
concentrations of up to 31µg/ml were selected for in vitro studies, and a dose of 62µg/animal 
was chosen for in vivo experiments. The choice of NM concentration/dose was based on our 
previous experience of testing the toxicity of these exact NM types to hepatocyte and 
macrophage cell lines and rodents (e.g. [19, 42-45]). Similarly, the time points (2-4 hours) used 
to assess the uptake of NMs by cells in vitro were based on our previous experience of 
investigating the uptake of NMs by macrophages and hepatocytes (e.g. [1,3]). For in vivo 
studies, an acute, 24 hour exposure was selected, and based on existing evidence of NM 
toxicity and biodistribution following pulmonary exposure (e.g. [41]).   
Experimental Details 
All materials were purchased from Sigma-Aldrich (Poole, UK) unless otherwise stated. 
NM Panel 
TiO2 NMs (NRCWE001, size: 10nm) were a kind gift from Prof. Hakan Wallan (NRCWE, 
Denmark). Gold unfunctionalised NMs (20nm) were purchased from Melorium Technologies 
(Rochester, USA).  The physico-chemical properties of the NMs used in this study have been 
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previously characterised [16, 37-39]. Briefly, the size of TiO2 NMs, as measured by TEM was 
80-400nm and NMs had a hydrodynamic diameter of 200nm when dispersed in cell culture 
medium [19, 44, 45]. Au NMs had a hydrodynamic diameter of 140nm when dispersed in 
complete cell culture medium and primary particle size of 85-110nm as measured by SEM [43]. 
NM preparation 
TiO2 NMs were supplied as dry powders. Au NMs (20nm) were supplied in an aqueous 
suspension. The NMs were dispersed in distilled water with 2% FCS at a concentration of 
1mg/ml, and then sonicated (in a bath sonicator) for 16 minutes following a protocol developed 
during the FP7 funded project ENPRA [46]. NMs were then diluted immediately in biological 
medium (varied according to whether in vitro or in vivo experiments were being conducted) to 
the required concentration. 
J774 cell culture and treatment 
The murine macrophage cell line J774.1 (European collection of cell cultures (ECACC)) was 
cultured in RPMI 1640 medium supplemented with 10% heat-inactivated FCS, 2 mM L-
glutamine, 100 U/ml penicillin/ streptomycin; termed complete macrophage cell culture medium 
(all obtained from Life Technologies, Paisley, UK) at 37°C in 5% CO2. For fixed cell imaging, 
cells were scraped from the culture flasks and seeded at a concentration of 5 x 104 cells/ml into 
Petri dishes (volume of 1ml) and incubated for 24 h at 37°C in 5% CO2. The medium was then 
removed, and the cells were treated with NMs (suspended in complete macrophage cell culture 
medium) at a concentration of 31µg/ml for 4 hours. Cells were then washed with medium and 
fixed with 10% formaldehyde at 4oC for one hour. The cells were then washed with phosphate 
buffered saline (PBS) and stored at 4oC (in PBS). 
 
For live cell imaging J774 cells were seeded at a concentration of 5 x 104 cells/ml into Petri 
dishes (at a volume of 1ml) and incubated at 37°C, in 5% CO2. After 24 hours cells were 
washed with complete macrophage cell culture medium. The cells were then exposed to NMs at 
a concentration of 15µg/ml (in complete macrophage cell culture medium) and imaged 
immediately over a period of 2 hours. 
 
C3A cell culture and treatment 
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The human hepatoblastoma C3A cell line was maintained in Minimum Essential Medium Eagle 
(MEM) with 10% FCS, 2 mM L-glutamine, 100 U/ml penicillin/ streptomycin, 1 mM sodium 
pyruvate and 1% nonessential amino acids (termed complete hepatocyte cell medium) at 37°C 
and 5% CO2 (all reagents obtained from Life Technologies, Paisley, UK). For fixed cell imaging, 
cells were removed from cell culture flasks using trypsin and seeded at a concentration of 5 x 
104 cells/ml into Petri dishes (volume of 1ml) and incubated for 24 h at 37°C. The medium was 
then removed, and the cells were treated with NMs (suspended in hepatocyte cell medium) at a 
concentration of 15 or 31µg/ml for 4 h. Cells were then washed with cell culture medium and 
fixed with 10% formaldehyde at 4oC for one hour. The cells were then washed with PBS, fixed 
with 10% formaldehyde at 4oC for one hour and stored at 4oC (in PBS). 
 
For live cell imaging, C3A cells were seeded at a concentration of 5 x 104 cells/ml into Petri 
dishes (volume of 1ml) and incubated at 37°C, in 5% CO2. After 24 hours incubation at 37°C, 
cells were washed with complete hepatocyte cell culture medium. The cells were then exposed 
to NMs at a concentration of 15 (TiO2) or 31 (Au) µg/ml (in complete hepatocyte cell culture 
medium) and imaged immediately over a period of 2 hours. 
 
In vivo studies 
Male Sprague Dawley rats (3 months old) were obtained from Biomedical Research Resources, 
Royal Infirmary Edinburgh (Edinburgh, UK). The research was conducted in accordance with 
UK Home Office regulations. Food and water were available ad libitum. Rats were 
anaesthetised with isoflurane and instilled intratracheally with a single dose of NM suspended in 
0.5ml saline to give a dose of 62µg/animal.  All animals recovered fully after this treatment and 
showed no ill effects.  After 24 hours, rats were sacrificed. Blood was removed from the 
abdominal aorta and collected into heparin blood tubes. The lungs were cannulated and 
lavaged with 4x8ml volumes of saline and the lavageate pooled into a single tube (termed 
bronchoalveolar lavage (BAL)). Lung and liver tissues were harvested and fixed in 10% 
formaldehyde after which the tissues were processed for paraffin wax histology and sectioned 
(5µm tissue sections). Tissues were de-waxed prior to imaging.  
 
To prepare BAL leukocytes for imaging, the BAL fluid was centrifuged at 850g for 2 minutes. 
The supernatant was removed and the cells resuspended in macrophage complete cell culture 
medium.  Cells were seeded at a concentration of 0.5 x 106 cells/ml in Petri dishes (1ml) and 
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incubated at 37oC for 1 hour to allow the cells to adhere. Cells were then washed with cell 
culture medium to remove non-adherent cells and fixed with 10% formaldehyde at 4oC for one 
hour. The cells were then washed with PBS and stored at 4oC (in PBS) until required for 
imaging. 
 
To prepare blood leukocytes for microscopy red blood cells were lysed with lysis buffer (0.15M 
ammonium chloride, 0.01M sodium bicarbonate, 1mM EDTA (disodium salt)). The suspension 
was centrifuged at 250g for 10 minutes at 4oC. The cell pellet was washed with PBS and the 
cells then centrifuged at 250g for 10 minutes at 4oC. The cell pellet was then resuspended in 
2ml complete macrophage cell culture medium. Cells were seeded at a concentration of 0.5 x 
106 cells/ml in Petri dishes (1ml) and incubated at 37oC for 1 hour to allow the cells to adhere. 
The cells were fixed with 10% formaldehyde at 4oC for one hour and then washed with PBS and 
stored (in PBS) at 4oC.  
 
Multimodal microscope 
The microscope setup used in this study has been described previously [47]. Briefly, a mode-
locked Nd:YVO4 laser source (PicoTrain, High-Q laser) produces the Stokes pulse (6 ps, 1064.4 
nm) and a 5 ps, frequency-doubled, 532 nm beam, which was used to pump a picosecond 
optical parametric oscillator (OPO) (Levante Emerald, APE). The OPO delivers a signal tunable 
in the range ~700 - 1000 nm that was used as a pump in the CARS process. The two beams 
are combined in a collinear geometry and focused on the sample using a high transmission x25 
water immersion objective (XL Plan N, Olympus) with 1.05 numerical aperture (NA). A laser-
scanning, confocal, inverted optical microscope (C1 Eclipse, Nikon BV, Amsterdam, 
Netherlands) is used to acquire images. Sets of appropriate short-pass and band-pass filters 
were used to transmit the desired nonlinear signals. The laser power at the sample was 12 mW 
and 8 mW for the pump and Stokes beams, respectively. A schematic diagram of the 
multimodal microscope used is presented in Figure 1. 
10	
	
  
Figure 1: Experimental set-up of the multimodal microscope. In this study CARS microscopy 
was used in combination with FWM to image TiO2 NMs, and with TPPL to image Au NMs 
(termed nonlinear optical (NLO) microscopy). Two-photon excitation fluorescence (TPEF), 
second harmonic generation (SHG), and sum frequency generation (SFG) and alternate modes 
of NLO accessible to the microscope but not considered in this study. 
Cell structure was visualised via the imaging of lipids using CARS microscopy (the CH2 vibration 
at 2845 cm-1 of lipids was excited); the pump laser was tuned to 817 nm (12240 cm-1) with the 
Stokes beam 1064.4 nm (9395 cm-1), giving a CARS signal at 662.9 nm (15085 cm-1). Short-
pass filters (SPF) (800SP, 750SP and 700SP), and a band-pass filter (660/13, FWHM = 13 nm) 
were used to collect the CARS signal. CARS microscopy was combined with additional NLO 
imaging modes to investigate the presence of NMs in cells. The approach used depended on 
the NM under investigation; CARS microscopy was combined with FWM to image TiO2 NMs or 
with TPPL to image Au NMs. z stacks were performed to confirm the internalisation of NMs by 
cells. All acquired images were 512x512 pixels in size and the acquisition time was 1s per 
image. 
Results and Discussion  
NM uptake by macrophage and hepatocyte cell lines 
In the first instance fixed J774 macrophage and C3A hepatocyte control cells (not exposed to 
NMs) were imaged using NLO microscopy. In order to visualise cell structure the pump and 
Stokes beams of the CARS microscope were tuned so that the frequency difference matched 
the Raman vibration of CH2 in lipids at 2845 cm-1. CARS microscopy was performed in 
combination with FWM and TPPL microscopy when imaging control cells to confirm that cellular 
Stokes
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structures did not give a FWM or TPPL signal in the absence of NMs (Figure 2). Using this 
approach we were able to visualise the cell structure of unlabelled macrophages and 
hepatocytes, with bright spots in the images corresponding to lipid droplets (Figure 2). No FWM 
or TPPL signal was observed in the absence of NMs. 
Multimodal microscopy images of J774 macrophages and C3A hepatocytes that had been 
exposed to TiO2 or Au NMs for 4 hours then fixed and imaged, are presented in Figure 2. The 
images demonstrate that macrophages and hepatocytes were able to accumulate TiO2 and Au 
NMs following a 4 hour exposure (Figure 2). NMs accumulate in the cytosol, with no localisation 
in the nucleus observed. Confirmation of internalisation of both NM types by cells into the cell 
interior is confirmed in the side panels of the images (yz and xz planes) (Figure 2).  
TiO2 NMs were detectable inside a large proportion of the macrophages imaged, but a smaller 
proportion of hepatocytes were observed to internalise TiO2 NMs. In fact, the concentration of 
TiO2 NMs in the hepatocyte exposures was reduced to 15µg/ml due to the large number of 
background NMs evident when a concentration of 31µg/ml was tested, which obscured 
visualisation of the cells (data not shown). This is likely to derive from the fact that macrophages 
are professional phagocytes, whereas hepatocytes are not. Therefore the mechanism of entry 
of NMs into cells and the extent of NM uptake is likely to vary according to the cell type under 
investigation (i.e. whether it is phagocytic or non-phagocytic). For an overview of the 
mechanisms by which NMs enter cells please refer to the following reviews [48-50]. 
Macrophages and hepatocytes were also capable of accumulating Au NMs following a 4 hour 
exposure (Figure 2). Uptake of Au NMs was observed in both cell types, however the uptake of 
Au NMs occurred to a lesser extent than that observed for TiO2 NMs. The quality of images 
obtained in this study is comparable to those acquired using confocal microscopy when 
visualising the uptake of fluorescent polystyrene NMs by stained macrophages [1] and 
hepatocytes [3] in previous studies. Importantly, unlike confocal microscopy, NLO microscopy 
has the advantage that it does not require the use of fluorescent NMs and cells do not have to 
be labelled to visualise their cell structure, and so sample preparation time is reduced. 
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Figure 2. NM uptake by macrophages and hepatocytes in vitro. J774 macrophages (top panel) 
and C3A hepatocytes (bottom panel) were exposed to complete cell culture medium (control), 
TiO2 or Au  NMs (green) for 4 hours, fixed and then imaged. Images were obtained using CARS 
microscopy at the Raman frequency 2845 cm-1 corresponding to the CH2 vibration in lipids to 
visualise cell structure (red) in combination with FWM (a frequency at 3060 cm-1) and TPPL 
(frequency of 609 nm) microscopy. Side panels present z-sections along the x and y planes and 
show the 3D distribution of cells confirming that NMs were present in the cell interior. 
Intensity profiles (along the blue lines) are presented alongside images of NM uptake by cells 
(fixed J774 macrophages and C3A hepatocytes) in Figure 3. Peaks in the intensity profiles 
represent NMs (or NM agglomerates/aggregates) in cells. Intensity profiles (along the blue lines) 
clearly demonstrate the contrast between cells (lipid) and NMs.  
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Figure 
3. Intensity profiles (along the blue line) of NM uptake (green) by macrophages and hepatocytes 
(red) (in fixed samples). Contrast between J774 macrophage and C3A hepatocyte cells (lipid) 
and TiO2 or Au NMs is demonstrated in the intensity profiles. Images were obtained using NLO 
microscopy (please refer to figure 2) and intensity profiles generated using Image J. 
Imaging of live cells confirmed that J774 macrophages and C3A hepatocytes were able to 
internalise TiO2 and Au NMs (Figure 4). The images presented are taken at the end of the 
exposure time of 2 hours (Figure 4). It was demonstrated that TiO2 NMs were internalised by 
both macrophages and hepatocytes (Figure 4). NMs are localised in the cytosol, with no 
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accumulation in the nucleus observed. Confirmation of NM uptake by cells can be visualised on 
the side panels of the images (yz, and xz planes). Au NMs were also internalised by 
macrophages and hepatocytes, but to a lesser extent than TiO2 NMs.  
  
Figure 4. J774 macrophage (top panel) and C3A hepatocyte (bottom panel) cell lines were 
exposed to cell culture medium (control), TiO2 or Au NMs for 2 hours. The images presented 
were taken from live cells at the end of the 2 hour exposure time. Visualisation of the cell 
structure (red) was obtained using CARS microscopy at the Raman frequency 2845 cm-1 which 
corresponds to the CH2 vibration in lipids. To image TiO2 NMs (green), FWM mixing at a 
frequency at 3060 cm-1 was performed. Au NMs (green) were imaged by TPPL microscopy at 
609 nm. Side panels present z-sections along the planes show the 3D distribution of cells 
confirming that the NMs were present in the cell interior.  
Obtained data indicate that TiO2 NMs were more avidly taken up by both macrophage and 
hepatocyte cell lines than Au NMs. Therefore, despite being administered at the same mass 
dose, there were less Au NMs taken up by cells when compared to TiO2 NMs. Gold is a dense 
metal in comparison to TiO2 and consequently fewer Au NMs are present in a similar mass of 
NM. This may explain why there were less Au NMs present in the cells.  Alternatively, TiO2 NMs 
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may be more readily phagocytosed than Au NMs. The aim of this study was not to investigate 
the relationship between NM physico-chemical properties and uptake. Instead a focus was 
placed on determining whether multimodal NLO microscopy was applicable to NMs that varied 
with respect to their composition. However, it is known that the optical properties of NMs are 
affected by their physico-chemical properties such as size, and shape (e.g [18]). Thus, as there 
is a huge diversity of NMs under development and use future studies could obtain a panel of 
NMs of the same composition but of varied size, shape or surface charge and determine if NM 
physico-chemical properties affects how easily they can be detected using multimodal NLO 
microscopy, and to determine the impact of physico-chemical properties on NM uptake by cells. 
Of interest is that existing studies have demonstrated that NM size, shape, agglomeration status 
and surface properties impact on their uptake by cells (e.g. [1, 3, 9, 26, 51]). In addition, 
knowledge of the properties of NMs which control uptake can be exploited in the design of 
nanomedicines in the future (reviewed in [49, 52]). Furthermore, future studies could explore 
whether NLO microscopy is suitable for assessing ‘mixed’ NM exposures (i.e. when cells / 
tissues are exposed to more than one NM at a time), as well as its applicability to more complex 
NMs (e.g. nanoclays, nanocomposites). Whilst the (lived and fixed cell) images presented 
confirm that Au and TiO2 NMs were internalised into the cell interior (in both macrophages and 
hepatocytes), the mechanism of uptake and intracellular fate of NMs was not investigated. 
However, it is possible to use NLO microscopy to assess the sub-cellular location of NMs. For 
example fluorescent stains could be used to enable the visualisation of specific organelles (e.g. 
lysosomes), and the co-location of NMs with these structures visualised using a combination of 
fluorescence and CARS microscopy. Furthermore, it is possible to identify specific organelles in 
cells/tissues without the requirement for fluorescent stains, using CARS microscopy alone 
(reviewed by [53]) or in combination with other imaging modalities [54, 55]. For example, the 
nucleus and mitochondria of cells have been imaged previously using CARS microscopy [56, 
57]. The ability to image a more diverse array of cellular organelles using multimodal NLO 
microscopy could therefore be the focus of future studies, as well as investigation of the 
intracellular fate of NMs. However, this approach may be limited by the target organelle under 
investigation, as CARS microscopy has been most widely applied to visualise lipids due to the 
stronger signal associated with C-H bond stretches in lipids and thus its applicability to other 
structures requires further investigation [54], and investigators will also need to consider 
whether the spatial resolution of NLO microscopy is adequate to image smaller organelles 
(<300nm in size).  
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The detection of NM uptake by cells using microscopy has been performed in nanotoxicology 
and nanomedicine studies to gain a better understanding of the sub-cellular location and 
mechanism of NM uptake into cells, and to identify what the potential consequences of NM 
uptake may be (beneficial and detrimental). This study did not quantify the uptake of NMs by 
cells as it was not possible to image single particles, as the resolution of the NLO microscope is 
~250-300 nm. However to better understand NM-cell interactions it would be of interest to 
quantify NM uptake by cells (i.e. number, mass or surface area of NMs internalised by a cell) 
[58, 59]. Currently there is a lack of knowledge regarding how the exposure dose of NMs is 
related to the cellular NM dose for in vitro experiments [59, 60]. However information on the 
cellular content (internal dose) of NMs is required to better design and interpret the findings of in 
vitro NM toxicity experiments [61], and to detect the targeted delivery of NMs into cells in 
therapeutic and diagnostic settings [62]. Although there is a desire to quantify NM uptake by 
cells, this has been a challenging area of activity. To date, flow cytometry has been used to 
quantify the uptake of fluorescent NMs by cells (e.g. [1, 63, 64]), and to a more limited extent to 
investigate the uptake of non-fluorescent NMs (e.g. [65, 66]). In addition, confocal microscopy 
has been used to quantify the uptake of fluorescent NMs, based on fluorescent intensity 
measurements (e.g. [67]). However these approaches are typically limited to fluorescent NMs. 
Alternatively, the number of NMs internalised by cells has been assessed using electron 
microscopy, which requires the number of NMs internalised to be counted by the investigator 
(e.g. [63, 68]). The resolution of NLO microscopy is sufficient to image particles that are ~250-
300 nm in size. Thus the ability of NLO microscopy to quantify the number of NMs internalised 
by cells could be explored in future studies, although it is likely that it will be limited to larger 
particles or NMs that are agglomerated or aggregated. 
NM uptake by cell and tissue samples obtained from in vivo studies 
Rats were exposed to NMs via intratracheal instillation and leukocytes isolated from blood and 
BAL 24 hours post exposure. It was challenging to detect NM uptake by blood and BAL 
leukocytes, and particularly difficult for blood leukocytes. The uptake of TiO2 NMs was observed 
in alveolar BAL and blood leukocytes (Figure 5). No Au NMs were detected in BAL or blood 
derived leukocytes (data not shown). A more comprehensive study is needed in order to 
investigate the interaction of NMs with leukocytes derived from blood and BAL. More 
specifically, future studies could use a range of time points to investigate if NM uptake by these 
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cell types changes over time as only one time point was investigated in this study. In addition 
rats could be exposed to a higher dose of NMs to increase the likelihood of detection.   
   
Figure 5. Rats were exposed to TiO2 NMs (62µg) via intratracheal instillation. 24 hours post 
exposure rats were sacrificed, a BAL performed, and blood was taken. Leukocytes were then 
isolated from BAL fluid and blood, fixed and imaged using NLO microscopy. Visualisation of the 
cell structure (red) was obtained using CARS microscopy at the Raman frequency 2845 cm-1 
which corresponds to the CH2 vibration in lipids. To image TiO2 NMs (green), FWM mixing at a 
frequency at 3060 cm-1 was performed. White arrows indicate which cells had internalised TiO2 
NMs. 
The structure of unstained lung and liver (fixed) tissue obtained from control rats (not exposed 
to NMs) were imaged via the visualisation of lipids (Figure 6). The images of control tissues 
were captured using multimodal NLO microscopy (combination of CARS, FWM and TPPL 
microscopy) to ensure that cellular structures did not give an FWM or TPPL signal in the 
absence of NMs (Figure 6). Imaging of lipids enabled tissue structure to be visualised, with no 
FVM or TPPL signal observed in the absence of NMs. Following intratracheal instillation, TiO2 
and Au NMs were detected in the alveolar region of the rat lung (Figure 6). TiO2 and Au NMs 
were also detected in the liver tissue following intratracheal instillation (Figure 6). Obtained data 
suggests that both NM types investigated were able to translocate from the lungs into the 
circulation and then accumulated in the liver. Assessment of the biodistribution of unmodified 
NMs has been a great challenge due to the necessity of detecting small quantities of NMs at a 
variety of target sites. As a consequence, biodistribution studies conducted to date have 
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focused on assessment of the accumulation of inherently fluorescent (e.g. quantum dots, silica) 
or modified (e.g fluorescently tagged or radiolabelled) NMs (e.g. [26, 41, 69-71]). In order to 
assess whether multimodal NLO microscopy could offer advantages over current approaches 
used to assess NM biodistribution, future studies should use a wider range of NM doses to 
identify the sensitivity of this approach, and whether tissue accumulation can be quantified. 
Evaluation of the biodistribution and accumulation of NMs following exposure via different 
exposure routes (e.g. ingestion) and in a wider range of tissues could also be considered. Whilst 
this study investigated the localisation of NMs in the lung and liver, it did not evaluate the toxicity 
exhibited by NMs in these tissues.  Evidence of uptake of NMs by a tissue does not imply that 
they will exert toxicity. Accordingly, further studies are required to evaluate the pulmonary and 
hepatic toxicity of the NMs tested in this study. In fact, the toxicity of these exact NMs has been 
investigated in hepatic and macrophage in vitro models [19, 43-45] 
   
 
Figure 6. Uptake of NMs by lung and liver tissue in vivo. Rats were exposed to PBS (control) 
TiO2 or Au NMs (62µg) via intratracheal instillation. Rats were sacrificed 24 hours post exposure 
and lung and liver tissue was removed and fixed. Tissue sections were then imaged using NLO 
19	
	
microscopy. Visualisation of the tissue structure (red) was obtained using CARS microscopy at 
the Raman frequency 2845 cm-1 which corresponds to the CH2 vibration in lipids. CARS 
microscopy was combined with FWM at a frequency at 3060 cm-1 to image TiO2 NMs (green) or 
TPPL at 609 nm to image Au NMs (green). The localisation of NMs in tissue is indicated by 
white arrows.   
Conclusion  
This study has demonstrated that multimodal NLO microscopy is a very promising and powerful 
technique that can be used to image the uptake of NMs by a variety of unstained cell and tissue 
types. Multimodal NLO microscopy can be used to investigate NM-cell interactions in vitro and 
in vivo, and may also be a useful tool when investigating NM biodistribution. As such we 
suggest that future studies investigating the efficacy and hazard of NMs in vitro and in vivo 
could use this imaging modality to a greater extent. In particular its ability to detect unmodified, 
non-fluorescent NMs in fixed cells and tissues, and live cells in three dimensions, with minimal 
sample preparation is greatly appealing.  
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